Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Vlad Ratziu, Ladrón de Guevara, Rifaat Safadi, Fred Poordad, Felipe Fuster, Jose Flores‐Figueroa, Marco Arrese, Anna Ludovica Fracanzani, Dafna Ben Bashat, K. Lackner, Tali Gorfine, Shaul Kadosh, R. Oren, Michael Halperin, Liat Hayardeny, Rohit Loomba, Scott L. Friedman, the ARREST investigator study group, Manal F. Abdelmalek, Francesco Angelico, M. Angélico, Juan Pablo Arancibia, Edouard Bardou‐Jacquet, Francisco Barrera, Charles F. Barish, Yaacov Baruch, Ziv Ben‐Ari, Thomas Berg, Marc Bourlière, Jérôme Boursier, Efrat Broide, Michal Carmiel, Douglas Denham, L. Di Cesare, Dan L. Dumitraşcu, Adi Francis, Samer Gawrieh, María Saraí González Huezo, Patrick Hillon, A De Molina Iracheta, Zeid Kayali, Limas Kupčinskas, George Lau, Lawrence Serfaty, Aline Le Cleach, C. Loguercio, M.P. Manns, Brittany Saldivar, Edward Mena, Luis Alonso Morales-Garza, J NEUTEL, L R Nikoleishvili, Mazen Noureddin, R. Pais, Alfonso Paredes, Marcelo Paredes, Runa Watkins, Antonio Picardi, Mario Pirisi, Gonzalo Pizarro Jofré, Liliana Preoțescu, Tarek Saadi, Didier Samuel, J.F. Sánchez-Ávila, Ingolf Schiefke, Oren Shibolet, M. Shadab Siddiqui, G. Torres-Mendoza, J.F. Trotter, Eugenia Tsai, Elizabeth C. Verna, E. Zuckerman, Dinah Zur, Arun J. Sanyal